These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3137632)

  • 1. Antidepressant effect of 5-methoxypsoralen: a preliminary report.
    Souêtre E; Salvati E; Belugou JL; Robert P; Brunet G; Darcourt G
    Psychopharmacology (Berl); 1988; 95(3):430-1. PubMed ID: 3137632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Methoxypsoralen increases evening sleepiness in humans: possible involvement of the melatonin secretion.
    Souêtre E; Salvati E; Belugou JL; Krebs B; Darcourt G
    Eur J Clin Pharmacol; 1989; 36(1):91-2. PubMed ID: 2917596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate in mild depression: a double-blind controlled trial.
    Mattes JA
    J Clin Psychiatry; 1985 Dec; 46(12):525-7. PubMed ID: 3905773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels and therapeutic response with trimipramine treatment of endogenous depression.
    Simpson GM; Pi EH; Gross L; Baron D; November M
    J Clin Psychiatry; 1988 Mar; 49(3):113-6. PubMed ID: 3279023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-MOP vs 5-MOP.
    Gasparro FP
    Exp Dermatol; 1992 Aug; 1(2):84-5. PubMed ID: 1365309
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-Methoxypsoralen increases the plasma melatonin levels in humans.
    Souetre E; Salvati E; Belugou JL; de Galeani B; Krebs B; Ortonne JP; Darcourt G
    J Invest Dermatol; 1987 Aug; 89(2):152-5. PubMed ID: 3598208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of nomifensine in different depressive syndromes.
    Overall JE
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):85-8. PubMed ID: 6370983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Methoxypsoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation.
    Tanew A; Ortel B; Rappersberger K; Hönigsmann H
    J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):333-8. PubMed ID: 3279089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of placebo-controlled trials with bupropion.
    Zung WW
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):104-14. PubMed ID: 6406436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Methoxypsoralen increases the sensitivity of the retina to light in humans.
    Souêtre E; De Galeani B; Gastaud P; Salvati E; Darcourt G
    Eur J Clin Pharmacol; 1989; 36(1):59-61. PubMed ID: 2917589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen.
    Berg M; Ros AM
    Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):217-20. PubMed ID: 7880762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fixed-dose clinical trial of fluoxetine in outpatients with major depression.
    Fabre LF; Putman HP
    J Clin Psychiatry; 1987 Oct; 48(10):406-8. PubMed ID: 3312176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of bupropion in elderly patients: preliminary observations.
    Kane JM; Cole K; Sarantakos S; Howard A; Borenstein M
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):134-6. PubMed ID: 6406442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern analysis of antidepressant response to fluoxetine.
    Fieve RR; Goodnick PJ; Peselow ED; Barouche F; Schlegel A
    J Clin Psychiatry; 1986 Nov; 47(11):560-2. PubMed ID: 3533909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity and acceptability of indalpine in a double-blind study versus placebo].
    Gisselmann A
    Encephale; 1984; 10(5):231-4. PubMed ID: 6151492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N; Ravic M; Bizière K
    Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder.
    Feighner J; Hendrickson G; Miller L; Stern W
    J Clin Psychopharmacol; 1986 Feb; 6(1):27-32. PubMed ID: 3081600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.
    Emslie GJ; Rush AJ; Weinberg WA; Kowatch RA; Hughes CW; Carmody T; Rintelmann J
    Arch Gen Psychiatry; 1997 Nov; 54(11):1031-7. PubMed ID: 9366660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.